Thomas P Miller

  • 19247 Citations
  • 57 h-Index
1978 …2016

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Thomas P Miller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.



Davis, T. P., Hersh, E. M., Weinstein, R. S., Miesfeld, R., Miller, T. P., Tsaprailis, G., Lynch, R., Chow, H., Nagle, R. B., Watts, G. S., Thomson, C., Roe, D., Stratton, S. P., Alberts, D. S., Hurley, L., Baker, A. F., Livingston, R. B., Dorr, R. T., Cress, A. E., Briehl, M. M., Mash, E. A., Duffy, J., Jones, S., Leibovitz, A., Meyskens, F., Moon, T., Trent, J., Newkirk, D., Von Hoff, D., Mount, D., Doetschman, T., Liebler, D., Marshall, J., McGovern, K., Grogan, T., Kraft, A., Powis, G., Peng, Y., Gerner, E., Aickin, M., Ritenbaugh, C., Taylor, C., Powell, M. B., Bowden, T., Taetle, R., Salmon, S., Ignatenko, N., Bhattacharyya, A. K., Futscher, B. W., Barton, J. K., Montfort, W. "., Roe, D., Garland, L. L., Doetschman, T. C., Kraft, A., Chow, H., Ellis, N. & Zeng, Y. -.

National Institutes of Health


Project: Research project


    Alberts, D. S., Hersh, E. M., Miller, T. P., Roe, D., Landowski, T. H., Dorr, R. T., Jones, S., Meyskens, F., Moon, T., Trent, J., Thomas, G., McGee, D., Durie, B. G., Dragovich, T., Gillies, R. J., Taylor, C., Dalton, W., Salmon, S. & Powis, G.

    National Institutes of Health


    Project: Research project


    Miller, T. P. & Cranmer, L.

    National Institutes of Health


    Project: Research project

  • Research Output

    A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520

    Puvvada, S. D., Li, H., Rimsza, L. M., Bernstein, S. H., Fisher, R. I., LeBlanc, M., Schmelz, M., Glinsmann-Gibson, B., Miller, T. P., Maddox, A. M., Friedberg, J. W., Smith, S. M. & Persky, D. O., Jan 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.

    Research output: Contribution to journalArticle

  • 17 Scopus citations

    Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

    Brown, J. R., Harb, W. A., Hill, B. T., Gabrilove, J., Sharman, J. P., Schreeder, M. T., Barr, P. M., Foran, J. M., Miller, T. P., Burger, J. A., Kelly, K. R., Mahadevan, D., Ma, S., Li, Y., Pierce, D. W., Barnett, E., Marine, J., Miranda, M., Azaryan, A., Yu, X. & 3 others, Nava-Parada, P., Mei, J. & Kipps, T. J., Jan 1 2016, In : Haematologica. 101, 7, p. e295-e298

    Research output: Contribution to journalLetter

    26 Scopus citations

    Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

    Persky, D. O., Miller, T. P., Unger, J. M., Spier, C. M., Puvvada, S., Dino Stea, B., Press, O. W., Constine, L. S., Barton, K. P., Friedberg, J. W., LeBlanc, M. & Fisher, R. I., Aug 8 2015, In : Blood. 125, 2, p. 236-241 6 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2

    Mahadevan, D., Morales, C., Cooke, L. S., Manziello, A., Mount, D. W., Persky, D. O., Fisher, R. I., Miller, T. P. & Qi, W., Jun 3 2014, In : PloS one. 9, 6, e95184.

    Research output: Contribution to journalArticle

  • 25 Scopus citations

    Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma

    Gustafson, H. L., Yao, S., Goldman, B. H., Lee, K., Spier, C. M., LeBlanc, M. L., Rimsza, L. M., Cerhan, J. R., Habermann, T. M., Link, B. K., Maurer, M. J., Slager, S. L., Persky, D. O., Miller, T. P., Fisher, R. I., Ambrosone, C. B. & Briehl, M. M., May 2014, In : American Journal of Hematology. 89, 6, p. 639-645 7 p.

    Research output: Contribution to journalArticle

  • 18 Scopus citations